scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1106904898 |
P356 | DOI | 10.1186/S10194-018-0914-7 |
P932 | PMC publication ID | 6131677 |
P698 | PubMed publication ID | 30203193 |
P50 | author | Alberto Raggi | Q37830338 |
Licia Grazzi | Q42702480 | ||
Antonio Russo | Q46653000 | ||
Domenico D'Amico | Q51846705 | ||
Carlo Lovati | Q52358451 | ||
Matilde Leonardi | Q56936660 | ||
Piero Barbanti | Q57160906 | ||
Erika Guastafierro | Q57303447 | ||
Chiara Scaratti | Q59766766 | ||
Luca Giani | Q84010295 | ||
Venusia Covelli | Q86075185 | ||
Gioacchino Tedeschi | Q87660234 | ||
Giulia Pierangeli | Q88383689 | ||
Giovanna Viticchi | Q91681294 | ||
Francesco Bono | Q104258958 | ||
Sabina Cevoli | Q114447259 | ||
Cinzia Aurilia | Q114447260 | ||
Laura Rapisarda | Q114447261 | ||
P2093 | author name string | Fabio Frediani | |
Marco Bartolini | |||
Paola Di Fiore | |||
P2860 | cites work | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q28083357 |
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q28111913 | ||
The International Classification of Headache Disorders, 3rd edition (beta version) | Q29392338 | ||
Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study | Q30966181 | ||
Workplace productivity. A review of the impact of migraine and its treatment | Q34219693 | ||
The stigma of migraine | Q34559119 | ||
The global burden of headache: a documentation of headache prevalence and disability worldwide | Q34611721 | ||
Chronic migraine plus medication overuse headache: two entities or not? | Q35522746 | ||
Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse | Q36234332 | ||
A systematic review of the psychosocial difficulties relevant to patients with migraine | Q36357101 | ||
Cost of medication overuse headache in Italian patients at the time-point of withdrawal: a retrospective study based on real data | Q36376857 | ||
Prevalence, burden, and cost of headache disorders | Q36479944 | ||
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients | Q36878256 | ||
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life | Q37176670 | ||
The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research | Q37176674 | ||
Humanistic and economic burden of nausea and vomiting among migraine sufferers | Q37730599 | ||
Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. | Q37861402 | ||
Disability in chronic daily headache: state of the art and future directions | Q37870786 | ||
Cost of disorders of the brain in Europe 2010. | Q37933664 | ||
The cost of headache disorders in Europe: the Eurolight project | Q37963926 | ||
Disability and quality of life in headache: where we are now and where we are heading. | Q38108474 | ||
Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review | Q38215466 | ||
Quality of life in primary headache disorders: A review | Q38427435 | ||
World Health Organization disability assessment schedule 2.0: An international systematic review | Q39002028 | ||
Validation of a migraine work and productivity loss questionnaire for use in migraine studies | Q39437824 | ||
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. | Q41689462 | ||
Cronbach's alpha | Q41957253 | ||
Migraine: the seventh disabler | Q43217625 | ||
Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse | Q45376934 | ||
Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study | Q45395151 | ||
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine | Q45848975 | ||
Assessing the impact of migraine onset on work productivity | Q48325470 | ||
Migraine is first cause of disability in under 50s: will health politicians now take notice? | Q50301000 | ||
Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine. | Q50550552 | ||
Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. | Q50617460 | ||
The migraine work and productivity loss questionnaire: concepts and design. | Q51976699 | ||
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults. | Q52674495 | ||
Burden of migraine: international perspectives. | Q53109838 | ||
Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). | Q53524572 | ||
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition | Q56627246 | ||
Multimorbidity in patients with chronic migraine and medication overuse headache | Q60698133 | ||
Gender and education inequalities in the cost of medication-overuse headache | Q60698145 | ||
The use of MIDAS in patients with chronic migraine and medication-overuse headache: should we trust it? | Q60698163 | ||
The Migraine Disability Assessment (MIDAS) Questionnaire: Translation and Reliability of the Italian Version | Q61698703 | ||
An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score | Q73016930 | ||
The validity and reproducibility of a work productivity and activity impairment instrument | Q74822877 | ||
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial | Q84582635 | ||
Chronic migraine with and without medication overuse: experience in a hospital series of 434 patients | Q87173394 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | migraine | Q133823 |
questionnaire | Q747810 | ||
P304 | page(s) | 85 | |
P577 | publication date | 2018-09-10 | |
P1433 | published in | The journal of headache and pain : official journal of the Italian Society for the Study of Headaches | Q26842211 |
P1476 | title | Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire | |
P478 | volume | 19 |
Search more.